Aranesp
Term · Oncology and biomedicine · MLC-T-ONC-000701
A drug used to treat anemia caused by chronic kidney disease and some types of chemotherapy. Aranesp is a form of erythropoietin (a substance naturally made by the kidneys) that is made in the laboratory. It helps the bone marrow make more red blood cells. Aranesp is a type of antianemic and a type of erythropoiesis-stimulating agent. Also called darbepoetin alfa.
| Identifier | MLC-T-ONC-000701 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | darbepoetin alfa |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000701",
"term": "Aranesp",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat anemia caused by chronic kidney disease and some types of chemotherapy. Aranesp is a form of erythropoietin (a substance naturally made by the kidneys) that is made in the laboratory. It helps the bone marrow make more red blood cells. Aranesp is a type of antianemic and a type of erythropoiesis-stimulating agent. Also called darbepoetin alfa.",
"synonyms": [
"darbepoetin alfa"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/aranesp/"
}
Record 2,409 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.